Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

Related Articles by Review for PubMed (Select 21800293)

1.

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer.

Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM.

Cancer. 2012 Mar 1;118(5):1202-11. doi: 10.1002/cncr.26439. Epub 2011 Jul 28.

2.

Does use of metformin protect against cancer in Type 2 diabetes mellitus?

Bo S, Benso A, Durazzo M, Ghigo E.

J Endocrinol Invest. 2012 Feb;35(2):231-5. Review.

PMID:
22490993
3.

Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.

Yin M, Zhou J, Gorak EJ, Quddus F.

Oncologist. 2013;18(12):1248-55. doi: 10.1634/theoncologist.2013-0111. Epub 2013 Nov 20. Review.

4.

[Metformin, an antidiabetic molecule with anti-cancer properties].

Beck E, Scheen AJ.

Rev Med Liege. 2013 Sep;68(9):444-9. Review. French.

PMID:
24180199
5.

Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.

Zhang ZJ, Bi Y, Li S, Zhang Q, Zhao G, Guo Y, Song Q.

Am J Epidemiol. 2014 Jul 1;180(1):11-4. doi: 10.1093/aje/kwu124. Epub 2014 Jun 10. Review.

6.

Anti-diabetic drug metformin: challenges and perspectives for cancer therapy.

Snima KS, Pillai P, Cherian AM, Nair SV, Lakshmanan VK.

Curr Cancer Drug Targets. 2014;14(8):727-36. Review.

PMID:
25329671
7.

Recent advances in the use of metformin: can treating diabetes prevent breast cancer?

Hatoum D, McGowan EM.

Biomed Res Int. 2015;2015:548436. doi: 10.1155/2015/548436. Epub 2015 Mar 19. Review.

8.

Metformin and breast cancer: basic knowledge in clinical context.

Pizzuti L, Vici P, Di Lauro L, Sergi D, Della Giulia M, Marchetti P, Maugeri-SaccĂ  M, Giordano A, Barba M.

Cancer Treat Rev. 2015 May;41(5):441-7. doi: 10.1016/j.ctrv.2015.03.002. Epub 2015 Mar 17. Review.

PMID:
25816698
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk